Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
After R&D head exits, Immunocore CEO pairs ambition with caution
CEO Bahija Jallal now has to advance Immunocore's ascending franchise without one of its key architects.
Darren Incorvaia
Feb 13, 2026 12:44pm
Why biotech IPOs are back for 2026
Feb 13, 2026 3:30am
Sponsored
How AI Is reshaping clinical trials and market access
Feb 9, 2026 8:00am
Building biopharma: The communities behind the science
Feb 12, 2026 9:30am
Sponsored
The Data Multiplier Effect: The 4 Forces Changing Biometrics
Feb 9, 2026 8:00am
Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg
Feb 13, 2026 10:10am
More News
What were the biggest clinical trial flops of 2025?
Feb 13, 2026 11:47am
Fierce Pharma
Vaccine makers facing increased volatility, uncertainty at FDA
Feb 13, 2026 11:12am
Fierce Biotech Layoff Tracker 2026: Seres, ARPA-H & more
Feb 13, 2026 9:00am
Sanofi's stunning CEO switch—Chutes & Ladders
Feb 13, 2026 8:30am
See more stories
